These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12088587)

  • 21. [Anti-meningococcal vaccines: diversity of vaccination policies and recommendations].
    Gendrel D
    Arch Pediatr; 2012 Sep; 19 Suppl 2():S70-6. PubMed ID: 22883370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Meningococcal vaccination in pregnancy.
    Abu Raya B; Sadarangani M
    Hum Vaccin Immunother; 2018 May; 14(5):1188-1196. PubMed ID: 29485347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meningococcal A, C, Y and W-135 polysaccharide-protein conjugate vaccines.
    Pace D; Pollard AJ
    Arch Dis Child; 2007 Oct; 92(10):909-15. PubMed ID: 17895339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinetics of Meningococcal Serogroup C-Specific Functional Antibody Levels Up to 15 Years after a Single Immunization with a Meningococcal Serogroup C Conjugate Vaccine during Adolescence.
    Stoof SP; van Ravenhorst MB; van Rooijen DM; de Voer RM; van der Klis FRM; Boland GJ; Sanders EAM; Berbers GAM; Teunis PF
    Clin Vaccine Immunol; 2017 Feb; 24(2):. PubMed ID: 27881489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meningococcal group C disease in Greece during 1993-2006: the impact of an unofficial single-dose vaccination scheme adopted by most paediatricians.
    Kafetzis DA; Stamboulidis KN; Tzanakaki G; Kourea Kremastinou J; Skevaki CL; Konstantopoulos A; Tsolia M
    Clin Microbiol Infect; 2007 May; 13(5):550-2. PubMed ID: 17378929
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recommendations for Use of Meningococcal Conjugate Vaccines in HIV-Infected Persons - Advisory Committee on Immunization Practices, 2016.
    MacNeil JR; Rubin LG; Patton M; Ortega-Sanchez IR; Martin SW
    MMWR Morb Mortal Wkly Rep; 2016 Nov; 65(43):1189-1194. PubMed ID: 27811836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A multivalent conjugate vaccine for prevention of meningococcal disease in infants.
    Harrison LH
    JAMA; 2008 Jan; 299(2):217-9. PubMed ID: 18182606
    [No Abstract]   [Full Text] [Related]  

  • 28. Serogroup A meningococcal conjugate vaccines in Africa.
    Kristiansen PA; Jørgensen HJ; Caugant DA
    Expert Rev Vaccines; 2015; 14(11):1441-58. PubMed ID: 26358167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Consensus recommendation for meningococcal disease prevention in children and adolescents in the Middle East region.
    Shibl A; Tufenkeji H; Khalil M; Memish Z;
    J Epidemiol Glob Health; 2012 Mar; 2(1):23-30. PubMed ID: 23856395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Survey on vaccination strategies used in different Italian Regions, for the 7-valent conjugate pneumococcal, meningococcal C and varicella vaccines].
    D'Ancona F; Alfonsi V; Ciofi degli Atti ML
    Ig Sanita Pubbl; 2006; 62(5):483-92. PubMed ID: 17206224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody persistence and booster response of a quadrivalent meningococcal conjugate vaccine in adolescents.
    Baxter R; Reisinger K; Block SL; Izu A; Odrljin T; Dull P
    J Pediatr; 2014 Jun; 164(6):1409-15.e4. PubMed ID: 24657122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A meningococcal vaccine for infants.
    Med Lett Drugs Ther; 2013 Nov; 55(1429):92. PubMed ID: 24220580
    [No Abstract]   [Full Text] [Related]  

  • 33. Meningococcal disease: the advances and challenges of meningococcal disease prevention.
    Yogev R; Tan T
    Hum Vaccin; 2011 Aug; 7(8):828-37. PubMed ID: 21832882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Licensure of a meningococcal conjugate vaccine (Menveo) and guidance for use - Advisory Committee on Immunization Practices (ACIP), 2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Mar; 59(9):273. PubMed ID: 20224545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is a single infant priming dose of meningococcal serogroup C conjugate vaccine in the United Kingdom sufficient?
    Findlow H; Borrow R
    Hum Vaccin Immunother; 2015; 11(6):1501-6. PubMed ID: 25912095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Meningococcal group C conjugate vaccines.
    Maclennan J
    Arch Dis Child; 2001 May; 84(5):383-6. PubMed ID: 11316676
    [No Abstract]   [Full Text] [Related]  

  • 37. Pneumococcal and Meningococcal Vaccination among Michigan Children with Sickle Cell Disease.
    Wagner AL; Shrivastwa N; Potter RC; Lyon-Callo SK; Boulton ML
    J Pediatr; 2018 May; 196():223-229. PubMed ID: 29555094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary and booster mucosal immune responses to meningococcal group A and C conjugate and polysaccharide vaccines administered to university students in the United Kingdom.
    Zhang Q; Lakshman R; Burkinshaw R; Choo S; Everard J; Akhtar S; Finn A
    Infect Immun; 2001 Jul; 69(7):4337-41. PubMed ID: 11401971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent trends in meningococcal epidemiology and current vaccine recommendations.
    Baltimore RS
    Curr Opin Pediatr; 2006 Feb; 18(1):58-63. PubMed ID: 16470164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of meningococcal C conjugate vaccination programs with and without catch-up campaigns in adolescents: Lessons learned from Bahia, Brazil.
    Evellyn do Macedo L; Ferreira VM; Feitosa CA; Nunes AMPB; Campos LC; Sáfadi MAP
    Hum Vaccin Immunother; 2018 May; 14(5):1131-1137. PubMed ID: 29236585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.